feed,title,long_url,short_url
Benzinga,AIM ImmunoTech Completes and Closes ATM Facility; Current Capital Expected to Meet Needs for Current Clinical Trials,https://www.benzinga.com/pressreleases/21/02/g19508015/aim-immunotech-completes-and-closes-atm-facility-current-capital-expected-to-meet-needs-for-curren,https://j.mp/2YPZkSN
